Shaffrey receives Cushing Award
Christopher Shaffrey, MD, chief of the Duke Spine Division, has received the American Association of Neurological Surgeons (AANS) Cushing Award for Technical Excellen
Duke Center for Brain and Spine Metastasis to Hold Second Annual Colloquium
The Duke Center for Brain and Spine Metastasis (DCBSM) presents the second annual Brain and Spine Metastasis Colloquium&n
Angels Among Us 5K and Walk is April 30
Angels Among Us 5K and Walk of Hope is a celebration of life, strength, courage and commitment.
Duke Neurosurgery Ranks at the Top for NIH Funding
Duke Neurosurgery has been ranked fifth among the nation's neurosurgery departments, based on National Institutes of Health (NIH) research grant funding, with a total of $9
New Treatment Options for Epilepsy, Movement Disorders
Since performing the first deep brain stimulation (DBS) procedure for epilepsy in North Carolina in 2019, neurosurgeon Derek Southwell, MD, PhD, has treated nearly 30 patients and is working to advance Duke’s armamentarium of innovative treatment options for drug-resistant epilepsy and movement disorders.
ICYMI: Some of the biggest stories from 2021
Glioblastoma, Alzheimer's, epilepsy, MIS, and more:
10 stories from Duke Neurosurgery and Duke Neurology that you may have missed in 2021
Gerald Grant, MD, Returns to Duke as Chair of Neurosurgery
Gerald Arthur Grant, MD, an internationally known surgeon-scientist, has been named the new chair of the Department of Neurosurgery at Duke University School of Medicine, effective April 1, 2022.
A third of caregivers of kids with cancer express vaccine hesitancy
A survey of parents and caregivers of children with cancer found that nearly a third of them expressed hesitancy to vaccinate their youngsters against COVID-19.
Women in Neurosurgery Outreach Program Promotes Mentorship for Young Students
Duke's Women in Neurosurgery (WINS) outreach program, established in early 2021, promotes mentorship to young students who are interested in pursuing a career in medicine especially in neurol
Duke Neurosurgery granted funding to study novel vaccine for pediatric brain tumors
Duke Neurosurgery and the CONNECT Consortium have been awarded a $1.8 million Food and Drug Administration R01 grant to fund a multi-institutional Phase 2 clinical trial of a novel vaccine to